Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus

Liver Transplantation and Surgery

Volumn 4, Issue 6, 1998, Pages 448-454

  Casavilla, E A ^a   Rakela, J ^a   Kapur, S ^a   Irish, W ^a   McMichael, J ^a   Demetris, A J ^a   Starzl, T E ^a   Fung, J J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031763086     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040605     Document Type: Article

References (25)

1. 1 Mateo R, Demetris A, Dico E, Frye C, Wang LF, el‐Sakhawi Y, et al. Early detection of the novo hepatitis C infection in post–liver transplant patients by reverse‐transcriptase polymerase chain reaction. Surgery 1993 ; 114: 442–448. MEDLINE
2. 2 Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992 ; 103: 317–322. MEDLINE
3. 3 Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992 ; 89: 1361–1365. MEDLINE
4. 4 Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994 ; 106: 994–999. MEDLINE
5. 5 Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus‐related liver disease. Hepatology 1991 ; 13: 619–626. MEDLINE
6. 6 Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, et al. Passive immunoprophylaxis after liver transplantation in HBsAg‐positive patients. Lancet 1991 ; 337: 813–815. MEDLINE
7. 7 Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with hepatitis B surface antigen. New Engl J Med 1993 ; 329: 1842–1847. MEDLINE
8. 8 Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long‐term outcome of hepatitis C infection after liver transplantation. New Engl J Med 1996 ; 334: 815–820. MEDLINE
9. 9 Boker KHW, Dalley G, Bahr MJ, Maschell H, Tillmann HL, Trutwein C, et al. Long‐term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997 ; 25: 203–210. MEDLINE
10. 10 Feray C, Gigoou M, Samuel DS, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994 ; 20: 1137–1143. MEDLINE
11. 11 Mateo R, Faruki H, Cooper D, Demetris AJ, Ehrlich G. Detection of hepatitis C virus RNA in liver and plasma by reverse‐transcriptase PCR using liquid hybridization. In: Ehrlich, G eds. PCR‐based diagnostics in infectious diseases. London: Blackwell Scientific. 1993 ; 124–132.
12. 12 Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958 ; 53: 457–481.
13. 13 Mantel PN. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966 ; 50: 163–170. MEDLINE
14. 14 Cox DR. Regression models and life tables. J R Stat Soc Series B. 1972 ; 34: 187–220.
15. 15 Casavilla A, Mateo R, Rakela J, Irish W, Demetris AJ, Starzl TE, et al. Impact of hepatitis C viral infection on survival following primary liver transplantation under FK 506 (Prograft™) [abstract]. Hepatology 1994 ; 20: 133A.
16. 16 Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, et al. Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury. Hepatology 1990 ; 12: 1295–1299. MEDLINE
17. 17 Rosman AS, Paronetto F, Galvin K, Williams RJ, Lieber CS. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and/or lobular hepatitis. Arch Intern Med 1993 ; 153: 965–969. MEDLINE
18. 18 Oshita M, Hayashi N, Kashara A, Hagiwara H, Mita E, Naito M, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994 ; 20: 1115–1120. MEDLINE
19. 19 Starzl TE, Van Thiel D, Tzakis AG, Iwatsuki S, Todo S, Marsh JW, et al. Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 1988 ; 260: 2542–2544. MEDLINE
20. 20 Lim HL, Lau GK, Davis GL, Dolson DJ, Lau JYN. Cholestatic hepatitis leading to hepatitis failure in a patient with organ‐transmitted hepatitis C virus infection. Gastroenterology 1994 ; 106: 248–253. MEDLINE
21. 21 Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996 ; 23: 971–976. MEDLINE
22. 22 Singh N, Gayowski T, Wagener MM, Marino IR. Increased infections. I. Liver transplant recipients with recurrent hepatitis C virus. Transplantation 1996 ; 61: 402–406. MEDLINE
23. 23 Ho M. Advances in understanding cytomegalovirus infection after transplantation. Transplant Proc 1994 ; 26: 7–11. MEDLINE
24. 24 Haider S, Coutinho M de L, Emond RT, Sutton RN. Tuberculin anergy and infectious mononucleosis. Lancet 1973 ; 2: 74. MEDLINE
25. 25 Nouri‐Aria KT, Arnold J, Davison F, Portmann BC, Meager A, Morris AG, et al. Hepatic interferon alfa gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection. Hepatology 1991 ; 13: 1029–1034. MEDLINE